These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34714324)

  • 1. Myocardial Infarction During the COVID-19 Pandemic.
    Fanaroff AC; Garcia S; Giri J
    JAMA; 2021 Nov; 326(19):1916-1918. PubMed ID: 34714324
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute myocardial infarction during the COVID-19 pandemic].
    Costabel JP; Muñoz F; Máscolo P; Candiello A; Viruel M; Belardi J
    Medicina (B Aires); 2021; 81(5):887-889. PubMed ID: 34633979
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 Pandemic and Possible Rebound Phenomenon in Incidence of Acute Myocardial Infarction.
    Čulić V; AlTurki A; Proietti R
    Can J Cardiol; 2021 Aug; 37(8):1294. PubMed ID: 33212202
    [No Abstract]   [Full Text] [Related]  

  • 4. Managed care for acute myocardial infarction survivors in the Silesian agglomeration during the COVID-19 pandemic.
    Wilkosz K; Wita K; Gąsior M; Cieśla D
    Kardiol Pol; 2021; 79(7-8):858-860. PubMed ID: 34029373
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in Emergency Department Arrival Times for Acute Myocardial Infarction During the COVID-19 Pandemic Suggest Delays in Care Seeking.
    Janke AT; Gettel CJ; Haimovich A; Kocher KE; Krumholz HM; Venkatesh AK
    Circ Cardiovasc Qual Outcomes; 2022 Feb; 15(2):e008402. PubMed ID: 35105172
    [No Abstract]   [Full Text] [Related]  

  • 6. How much is good enough? Insights from myocardial infarction incidence during COVID-19 pandemic.
    Fedorowski A; Erlinge D
    Int J Cardiol; 2021 Jul; 334():24-25. PubMed ID: 33857541
    [No Abstract]   [Full Text] [Related]  

  • 7. [COVID-19 pandemic : Effects on clinical care of cardiovascular patients in spring 2020].
    Zeymer U; Gitt A; Thiele H
    Herz; 2021 Mar; 46(2):115-119. PubMed ID: 33590283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial infarction in times of COVID-19.
    Ibáñez B
    Rev Esp Cardiol (Engl Ed); 2020 Dec; 73(12):975-977. PubMed ID: 33139226
    [No Abstract]   [Full Text] [Related]  

  • 9. Initial Single-Center ST-Segment Elevation Myocardial Infarction Experience in New York Before and During the COVID-19 Pandemic.
    Medranda GA; Brahmbhatt K; Alawneh B; Marzo KP; Schwartz RK; Green SJ
    Cardiovasc Revasc Med; 2022 Jan; 34():80-85. PubMed ID: 33526393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Challenges of ST-Segment Elevation Myocardial Infarction Within the Constraint of COVID-19 Pandemic.
    Shereef H; Yassin AS; Subahi A; Ali O
    Am J Ther; 2021 Nov-Dec 01; 28(6):e738-e740. PubMed ID: 34757967
    [No Abstract]   [Full Text] [Related]  

  • 11. Regional differences in hospital admissions for ST-elevation and non-ST-elevation myocardial infarctions during the Coronavirus disease-19 (COVID-19) pandemic in Austria.
    Kiblboeck D; Kellermair J; Siostrzonek P; Steinwender C
    Wien Klin Wochenschr; 2020 Jul; 132(13-14):362-364. PubMed ID: 32533442
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to letter to the editor: Revascularization strategy in patients with acute ST-elevation myocardial infarction amid COVID-19 pandemic.
    Li YH; Wang MT; Huang WC; Hwang JJ
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 3):774-775. PubMed ID: 32888844
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of the COVID-19 Pandemic on ST-Segment-Elevation Myocardial Infarction Presentations and In-Hospital Outcomes.
    Wilson SJ; Connolly MJ; Elghamry Z; Cosgrove C; Firoozi S; Lim P; Sharma R; Spratt JC
    Circ Cardiovasc Interv; 2020 Jul; 13(7):e009438. PubMed ID: 32600109
    [No Abstract]   [Full Text] [Related]  

  • 14. Revascularization strategy in patients with acute ST-elevation myocardial infarction amid COVID-19 pandemic.
    Kow CS; Hasan SS
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 3):772-773. PubMed ID: 32798030
    [No Abstract]   [Full Text] [Related]  

  • 15. Why Fibrinolytic Therapy for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic Is Not Your New Best Friend.
    Kirtane AJ; Bangalore S
    Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006885. PubMed ID: 32339025
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19-Specific Strategies for the Treatment of ST-Segment Elevation Myocardial Infarction in China.
    Ranard LS; Parikh SA; Kirtane AJ
    J Am Coll Cardiol; 2020 Sep; 76(11):1325-1327. PubMed ID: 32807587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing Patients With ST-Elevation Myocardial Infarction at the Epicenter of the COVID-19 Pandemic.
    Elbaum L; Rashed E; Kamran M
    Curr Probl Cardiol; 2021 Mar; 46(3):100716. PubMed ID: 33081993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of COVID-19 on short-term prognosis of ST-segment elevation myocardial infarction patients receiving primary percutaneous coronary intervention in Wuhan China.
    Lu Q; Wang JL; Chen ZN; Fu WB; Liu HJ; Ding SF
    Rev Cardiovasc Med; 2021 Mar; 22(1):247-256. PubMed ID: 33792269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of ST-Segment Elevation Myocardial Infarction Volume Trends During The COVID-19 Pandemic.
    Lotfi AS; Capatina A; Kugelmass AD
    Am J Cardiol; 2020 Sep; 131():132-133. PubMed ID: 32732009
    [No Abstract]   [Full Text] [Related]  

  • 20. Delay, Death, and Heterogeneity of Primary PCI During the COVID-19 Pandemic: An International Perspective.
    Park DW; Yang Y
    J Am Coll Cardiol; 2020 Nov; 76(20):2331-2333. PubMed ID: 33183507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.